|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/70 | |
| A61K 31/436 | |||
| C07D 491/00 |
| (11) | Number of the document | 2948134 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14743123.3 |
| Date of filing the European patent application | 2014-01-24 | |
| (97) | Date of publication of the European application | 2015-12-02 |
| (45) | Date of publication and mention of the grant of the patent | 2020-03-04 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/013066 |
| Date | 2014-01-24 |
| (87) | Number | WO 2014/117035 |
| Date | 2014-07-31 |
| (30) | Number | Date | Country code |
| 201361756406 P | 2013-01-24 | US |
| (72) |
KASPAR, Roger L., US
SPEAKER, Tycho, US
|
| (73) |
Palvella Therapeutics, Inc.,
125 Strafford Avenue, Suite 360, Wayne, Pennsylvania 19087,
US
|
| (54) | COMPOSITIONS FOR TRANSDERMAL DELIVERY OF MTOR INHIBITORS |
| COMPOSITIONS FOR TRANSDERMAL DELIVERY OF MTOR INHIBITORS |